Shopping Cart
- Remove All
- Your shopping cart is currently empty
Carmofur (HCFU) is a highly potent acid ceramidase inhibitor, used in the treatment of breast and colorectal cancer. Carmofur has been known to induce leukoencephalopathy.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
50 mg | $34 | In Stock | |
100 mg | $48 | In Stock | |
200 mg | $59 | In Stock | |
1 mL x 10 mM (in DMSO) | $30 | In Stock |
Description | Carmofur (HCFU) is a highly potent acid ceramidase inhibitor, used in the treatment of breast and colorectal cancer. Carmofur has been known to induce leukoencephalopathy. |
Targets&IC50 | AC:29 ± 5 nM |
In vitro | Carmofur is one of the masked compounds of 5-FU, which was modified for more potent antineoplastic activity and less toxicity. Carmofur is converted in vivo into 5-FU directly or via intermetabolites, such as 1-(carboxypentylcarbamoyl)-5-fluorouracil and/or 1-(carboxypropylcarbomoyl)-5-fluorouraci. Carmofur and its metabolites gradually accumulate in the brain during continuous administration and are removed very slowly. Carmofur has potent neurotoxicity which can produce severe leucoencephalopathy resembling methotrexate leucoencephalopathy both clinically and on brain CT, together with a cerebellar syndrome similar to that following 5-FU neurotoxicity. [1] |
Alias | HCFU |
Molecular Weight | 257.26 |
Formula | C11H16FN3O3 |
Cas No. | 61422-45-5 |
Smiles | CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O |
Relative Density. | 1.26 g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 40 mg/mL (155.48 mM), Sonication is recommended. H2O: < 1 mg/mL (insoluble or slightly soluble) Ethanol: 10 mg/mL (38.87 mM) | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.